Sep 04, 2025
What's driving medical benefit spend? Prime Therapeutics trend report shares new clues
Jun 25, 2025
Prime Therapeutics' leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years
Oct 24, 2024
Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity
Oct 15, 2024
Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report(TM) goes behind the numbers
Oct 10, 2024
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Oct 07, 2024
Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice
Oct 03, 2024
Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance
Sep 12, 2024
Prime/Magellan Rx's Advocate+(TM) elevates specialty pharmacy experience, simplifies health care journey
Sep 06, 2024
Prime Therapeutics recognized at PBMI for award-winning solutions, leaders
Jun 19, 2024
Prime/MRx's new Pharmacy Match technology-driven solution expands specialty pharmacy access and choice
Jun 10, 2024
Prime Therapeutics hires industry veteran Mike Edwards to lead new market-focused organization
Apr 11, 2024
Prime Therapeutics and Magellan Rx present award-winning and industry-leading clinical insights at AMCP
Mar 13, 2024
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
Dec 28, 2020
Notice of incorrect information sent to some Washington health plan members
Dec 22, 2020
Prime Therapeutics' predictive model expands efforts to reduce potential misuse and abuse of opioids
Dec 16, 2020
Prime Therapeutics and Takeda agree to outcomes-based arrangement for Hemophilia A treatment ADVATE® [Antihemophilic Factor (Recombinant)]
Oct 29, 2020
Blue Cross and Blue Shield of Nebraska, Prime Therapeutics provide free over-the-counter medicines, products to Medicare Advantage members
Oct 20, 2020
Study shows taking Entresto® as prescribed associated with lowering total cost of care by $6.7 million
Oct 19, 2020
Annual drug costs increased $1.25 billion for members with more than $250,000 in annual drug spend - doubling in four years
Oct 19, 2020
Lower total cost of care, hospitalizations, emergency visits associated with greater drug adherence among Medicare Advantage members